Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan on Coronary Artery Plaque in Hypertensive Patients
NCT02400775Phase 4Withdrawn
- Sponsor
- Takeda
- Start
- Mar 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azilsartan in essential hypertension, sponsored by Takeda. Planned start Mar 2015; status: withdrawn.
02
Drugs
azilsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02400775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400775.